Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P36
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -30.98% |
| Q3 2025 | 80.27% |
| Q2 2025 | -414.87% |
| Q1 2025 | 242.83% |
| Q4 2024 | -82.26% |
| Q3 2024 | 74.52% |
| Q2 2024 | -128.55% |
| Q1 2024 | -150.76% |
| Q4 2023 | 462.86% |
| Q3 2023 | -613.02% |
| Q2 2023 | 101.97% |
| Q1 2023 | -24.61% |
| Q4 2022 | -279.87% |
| Q3 2022 | 89.33% |
| Q2 2022 | 68.29% |
| Q1 2022 | -373.00% |
| Q4 2021 | 59.23% |
| Q3 2021 | -15.07% |
| Q2 2021 | 6.21% |
| Q1 2021 | -360.38% |
| Q4 2020 | -56.73% |
| Q3 2020 | 46.39% |
| Q2 2020 | -38.42% |
| Q1 2020 | 3.50% |
| Q4 2019 | -4.89% |
| Q3 2019 | -3.39% |
| Q2 2019 | -6.55% |
| Q1 2019 | 5.54% |
| Q4 2018 | -33.17% |
| Q3 2018 | 10.67% |
| Q2 2018 | 49.16% |
| Q1 2018 | -88.40% |
| Q4 2017 | 8.31% |
| Q3 2017 | -213.42% |
| Q2 2017 | 71.40% |
| Q1 2017 | -15.75% |
| Q4 2016 | 29.63% |
| Q3 2016 | 55.14% |
| Q2 2016 | -312.10% |
| Q1 2016 | -7.08% |